Novartis AG (NVS) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Novartis AG (NVS) over the last 10 years.
|Medical||Large Cap Pharmaceutical||$202.921B||$48.518B|
|Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.|